| Alexandra Katherine Jones, MD | |
|
780 Broad St, Montoursville, PA 17754-2419 | |
| (570) 368-2870 | |
| (570) 368-4463 |
| Full Name | Alexandra Katherine Jones |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 780 Broad St, Montoursville, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689170706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD473301 (Pennsylvania) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
USA Today's On Politics: Sen. Mary Landrieu, D-La., took to the Senate floor Thursday "to defend the so-called 'Louisiana purchase.'" Describing the deal as a "'bipartisan effort,'" she said she made no apologies for leading the push to cut a deal "to get Louisiana $300 million in extra Medicaid funds inserted into the health care bill" (Kiely, 2/4).
To improve the quality of HIV care and treatment nationwide, 17 measures such as screening and prevention for infections and monitoring of antiretroviral therapy should be adopted uniformly, according to a work group led by a Kaiser Permanente researcher.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
› Verified 3 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
USA Today's On Politics: Sen. Mary Landrieu, D-La., took to the Senate floor Thursday "to defend the so-called 'Louisiana purchase.'" Describing the deal as a "'bipartisan effort,'" she said she made no apologies for leading the push to cut a deal "to get Louisiana $300 million in extra Medicaid funds inserted into the health care bill" (Kiely, 2/4).
To improve the quality of HIV care and treatment nationwide, 17 measures such as screening and prevention for infections and monitoring of antiretroviral therapy should be adopted uniformly, according to a work group led by a Kaiser Permanente researcher.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Katherine Jones, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Alexandra Katherine Jones, MD 780 Broad St, Montoursville, PA 17754-2419 Ph: (570) 368-2870 |
News Archive
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
USA Today's On Politics: Sen. Mary Landrieu, D-La., took to the Senate floor Thursday "to defend the so-called 'Louisiana purchase.'" Describing the deal as a "'bipartisan effort,'" she said she made no apologies for leading the push to cut a deal "to get Louisiana $300 million in extra Medicaid funds inserted into the health care bill" (Kiely, 2/4).
To improve the quality of HIV care and treatment nationwide, 17 measures such as screening and prevention for infections and monitoring of antiretroviral therapy should be adopted uniformly, according to a work group led by a Kaiser Permanente researcher.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
› Verified 3 days ago
Dr. Sandra C. Beall, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 780 Broad St, Ste 4, Montoursville, PA 17754 Phone: 570-368-2870 Fax: 570-368-4463 |